AR and metabolic dysfunction-associated steatohepatitis: Moreover, recently, an AR-driven oncogene, cell cycle-related kinase (CCRK), collaborated with obesity-induced pro-inflammatory signaling to promote NASH-related hepatocarcinogenesis [43].